Report of the second meeting on the development of influenza vaccines that induce broad-spectrum and long-lasting immune responses, World Health Organization, Geneva, Switzerland, 6-7 December 2005

Vaccine

Volumn 24, Issue 23, 2006, Pages 4897-4900

  Hampson, Alan W ^a   Osterhaus, Albert D M E ^b   Pervikov, Yuri ^c   Kieny, Marie Paule ^c  

^a Erasmus University ^*  (Australia)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Broad spectrum heterotypic immunity; Influenza vaccine; Pandemic influenza

Indexed keywords

DNA VACCINE; INFLUENZA VACCINE; LIVE VACCINE; PROTEIN M2; RECOMBINANT VACCINE;

CONFERENCE PAPER; CROSS REACTION; DEVELOPING COUNTRY; DRUG DELIVERY SYSTEM; EPIDEMIC; HUMAN; IMMUNE RESPONSE; IMMUNITY; INFLUENZA VIRUS; INFLUENZA VIRUS A; INFLUENZA VIRUS B; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL; SWITZERLAND; VACCINATION; WORLD HEALTH ORGANIZATION;

HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; WORLD HEALTH ORGANIZATION;

EID: 33646865673     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.03.035     Document Type: Conference Paper

References (1)

1. Cassetti MC, Couch R, Wood J, Pervikov Y. Report of meeting on the development of influenza vaccines with broad spectrum and long-lasting immune responses, World Health Organization, Geneva, Switzerland, 26-27 February 2004. Vaccine 2005;23(13):1529-33.